<DOC>
	<DOCNO>NCT00161668</DOCNO>
	<brief_summary>This study design assess safety Mylotarg therapy routine practice .</brief_summary>
	<brief_title>Study Evaluating Mylotarg ( Gemtuzumab Ozogamicin ) Usual Care</brief_title>
	<detailed_description />
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Gemtuzumab</mesh_term>
	<criteria>Treated Mylotarg Provide ICF</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>Leukemia</keyword>
</DOC>